Osteoporosis, with current studies that focus on advances in diagnosis and natural history of male and postmenopausal osteoporosis. The study on male osteoporosis include a collaborative study with outside investigators is examining the utility of lateral spine bone densitometry in identifying men with osteoporosis and low trauma fractures.
Hypophosphatemic disorders, including X-link hypophosphatemic rickets and tumor-induced osteomalacia. My ongoing research study, in collaboration with Dr. L Darryl Quarles at the University of Kansas, seeks to further confirm and extend our understanding of the role of FGF-23 in human disorders of phosphate homeostasis, including patients with chronic kidney disease. Pending studies include primary and sub-investigator directed Phase 1 / 2 first in human studies examining the effects of a monoclonal antibody and enzyme replacement therapy for X-linked hypophosphatemic rickets and hypophosphatasia, respectively.
Education and Training
- Fellow in Endocrinology, Medicine, Duke University, 1993 - 1997
- Instructor, Medicine, Yale University, 1992 - 1993
- Medical Resident, Medicine, Yale University, 1989 - 1992
- M.D., University of Chicago, 1989
- X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP) UX023-CL401
- An integrated and diverse genomic medicine program for undiagnosed diseases
- Clinical indicators for early bone loss in Common Variable Immunodeficiency
- Endocrinology and Metabolism Training Program
- UX023-CL303 XLH Study
- UX023T-CL201 TIO Study
- UX023-CL203 Adult Extension Study